Bms.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
85% 
Page quality
75% 
Page structure
95% 
Link structure
63% 
Server
80% 
External factors
100% 
SEO Score
Response time
0.52 s
File size
133.80 kB
Words
785
Media files
15
Number of links
168 internal / 23 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Global Biopharmaceutical Company - Bristol Myers Squibb
The length of the page title is perfect. (525 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
The meta description is too long: 1037 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.bms.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width,initial-scale=1
descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
google-site-verificationMOA_zkwraH_JsReOcsUwqULQpxy_bHgguqaLGpEjiAQ
langen-us
twitter:cardsummary
twitter:sitewww.bms.com
twitter:urlhttps://www.bms.com/
twitter:titleGlobal Biopharmaceutical Company - Bristol Myers Squibb
twitter:descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
twitter:imagehttps://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg
twitter:image:altTwitter
og:titleGlobal Biopharmaceutical Company - Bristol Myers Squibb
og:typewebsite
og:urlhttps://www.bms.com/
og:imagehttps://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg
og:descriptionBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
X-UA-CompatibleIE=edge,chrome=1
charsetutf-8

Test up to 1.000 webpages of bms.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 785 words. That's ok.
20.6% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
3 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 10.5 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
This page loads 9 JavaScript files. This may affect the load time negatively.
A viewport "width=device-width,initial-scale=1" is provided.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 16 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
.../bms/us/en-us/logos/bms-rebrand-logo.svgbmsnull
/assets/bms/us/en-us/icons/Facebook.svgFacebookFacebook
/assets/bms/us/en-us/icons/Instagram.svgInstagramInstagram
/assets/bms/us/en-us/icons/Twitter.svgTwitterTwitter
/assets/bms/us/en-us/icons/Linkedin.svgLinkedInLinkedIn
/assets/bms/us/en-us/icons/YouTube.svgYouTubeYouTube

Page structure

H1 heading
(Critically important)
Global Biopharmaceutical Company - Bristol Myers Squibb
The H1 heading is perfect.
Headings
(Important)
Some headings do not have any content.

Heading structure

Heading levelContent
H1 Global Biopharmaceutical Company - Bristol Myers Squibb
H2 Explore BMS
H2 Moving forward. Together.
H2 Looking for answers?
H3 Empty heading
H3 Empty heading
H3 Bristol Myers Squibb 2023 ESG Report
H4 Our latest cell therapy milestone >
H4 ASPIRE: Our commitment to address health inequities in low- and middle-income countries >
H4 Science Firsthand: Translating the promise of cell therapy >
H4 Scientific media resources >
H4 Advancing cell therapy: Shaping our approach today to reach more patients tomorrow >
H4 Building a Better Future:
H5 BMS has received accelerated approval from the FDA for our CAR T cell therapy to treat relapsed or refractory follicular lymphoma.
H5 Bringing the science of cell therapy into autoimmune diseases >
H5 Researching lung cancer treatments to give more patients better outcomes >
H5 Our scientists are driven by curiosity to pursue the best outcomes possible for patients. Explore our strategic research approaches that allow us to investigate the potential of our early discoveri...
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 23 external links on this page.

Found links on this page

LinkAttributesAnchor text
/patient-and-caregivers/our-me...Our medicines
/life-and-science.htmlOur stories
/investors.htmlInvestors
https://www.bms.com/IMG-ALT bms
A-TITLE bms
https://www.bms.com/Anchor Skip to main content
/about-us/contact-us.htmlContact us
https://careers.bms.com/External Subdomain Careers
https://www.bms.com/United States
https://www.bms.com/arSpanish
https://www.bms.com/brPortuguese
https://www.bms.com/ca/enEnglish
https://www.bms.com/ca/frFrench
https://www.bms.com/clText duplicate Spanish
https://www.bms.com/coText duplicate Spanish
https://www.bms.com/mxText duplicate Spanish
https://www.bms.com/peText duplicate Spanish
https://www.bms.com/Text duplicate English
https://www.bms.com/auText duplicate English
https://www.bms.com/cnSimplified Chinese
https://www.bms.com/inText duplicate English
https://www.bms.com/jpJapanese
https://www.bms.com/krKorean
https://www.bms.com/nzText duplicate English
https://www.bms.com/sgText duplicate English
https://www.bms.com/twTraditional Chinese
https://www.bms.com/th/enText duplicate English
https://www.bms.com/th/thThai
https://www.bms.com/atGerman
https://www.bms.com/beText duplicate English
https://www.bms.com/be/nlDutch
https://www.bms.com/be/frText duplicate French
https://www.bms.com/czCzech
https://www.bms.com/dkDanish
https://www.bms.com/fiFinnish
http://www.bms.com/frSubdomain Text duplicate French
https://www.bms.com/deText duplicate German
https://www.bms.com/grGreek
https://www.bms.com/huHungarian
https://www.bms.com/ieText duplicate English
http://www.bms.it/Pages/Home.aspxExternal Subdomain Italian
https://www.bms.com/luText duplicate English
https://www.bms.com/nl/enText duplicate English
https://www.bms.com/nlText duplicate Dutch
https://www.bms.com/noNorwegian
https://www.bms.com/plPolish
https://www.bms.com/ptText duplicate Portuguese
https://www.bms.com/roRomanian
https://www.bms.com/esText duplicate Spanish
https://www.bms.com/seSwedish
https://www.bms.com/chText duplicate German
https://www.bms.com/ch/frText duplicate French
https://www.bms.com/gbText duplicate English
https://www.bms.com/ilHebrew
https://www.bms.com/sa/enText duplicate English
https://www.bms.com/sa/arArabic
https://www.bms.com/trTurkish
https://www.bms.com/ae/enText duplicate English
https://www.bms.com/ae/arText duplicate Arabic
/other-markets.htmlDistributor Markets
/patient-and-caregivers/our-me...Medicines >
https://careers.bms.com/jobsExternal Subdomain Careers >
https://news.bms.com/External Subdomain Press Releases >
https://www.bmsmedinfo.com/External Subdomain Medical Information >
/patient-and-caregivers.htmlPatients & caregivers
/patient-and-caregivers/our-me...Text duplicate Our medicines
/patient-and-caregivers/get-he...Get help paying for your medicines
/patient-and-caregivers/patien...Patient resources
/patient-and-caregivers/risk-e...Risk evaluation and mitigation strategies (REMS)
/patient-and-caregivers/patien...Immunology patient resources
/about-us/responsibility/posit...Our position on generic drugs
/about-us/responsibility/posit...Our position on drug pricing
/patient-and-caregivers/patien...Psoriasis around the world
/healthcare-providers.htmlHealthcare providers
/healthcare-providers/early-pa...Learn about pre-approval access
/healthcare-providers/post-stu...Learn about post study drug access
/assets/bms/us/en-us/pdf/BMS-3...New window 340B practice fact sheet
http://www.bmsmedinfo.com/New window External Subdomain U.S. medical information
/researchers-and-partners/clin...Clinical trials
/healthcare-providers/early-pa...Pre-approval access request system
/healthcare-providers/post-stu...Post study drug access request system
/researchers-and-partners.htmlResearchers
/researchers-and-partners/area...Areas of focus
/researchers-and-partners/in-t...In the pipeline
/researchers-and-partners/our-...R&D expert voices
/researchers-and-partners/prom...Our efforts in STEM
/researchers-and-partners/clin...Clinical trials & research
/researchers-and-partners/inde...Independent research
/researchers-and-partners/bms-...The Thomas O. Daniel research incubator and collaboration center
https://www.plengegen.com/External Subdomain Perspectives from our head of research
/researchers-and-partners/our-...Research publications
/researchers-and-partners/clin...Disclosure commitment
https://fasttrack.bms.com/LoginExternal Subdomain Investigator sponsored research portal
/researchers-and-partners/inde...Areas of interest & competitive research grants
/researchers-and-partners/inde...Compound & technology requests
/researchers-and-partners/inde...Data sharing request process
/researchers-and-partners/tran...Translational medicine
/investors.htmlText duplicate Investors
/investors/stock-information.htmlStock information
/investors/financial-reporting...Financial reporting
/investors/analyst-coverage.htmlAnalyst coverage
/investors/events-and-presenta...Events and presentations
/investors/shareholder-service...Shareholder services
/investors/celgene-acquisition...Acquisition-related information for Celgene shareholders
/investors/investor-contacts.htmlInvestor contacts
https://annual-report.bms.com/New window External Subdomain Annual report 2023
/investors/stock-information/d...Dividend history
/investors/stock-information/s...Stock split history
/investors/stock-information/i...Investment return calculator
/investors/financial-reporting...SEC filings
/investors/financial-reporting...Quarterly results
/investors/financial-reporting...Product sales summary
/investors/financial-reporting...Annual reports archive
/investors/shareholder-service...Annual meeting of shareholders
/business-development.htmlBusiness development
/business-development/existing...Our partnerships
/business-development/why-part...Why partner with us
/business-development/science-...Areas of interest
/business-development/partneri...Business development leadership team
/business-development/begin-di...Begin a discussion
/business-development/early-in...Early innovation at BMS
/assets/bms/us/en-us/pdf/bms-b...New window Download business development brochure
/business-development/early-in..."Golden Ticket" contests
https://www.bms.com/media.htmlNews
/media/press-releases.htmlPress releases
/life-and-science.htmlText duplicate Our stories
/media/medical-meetings.htmlMedical meetings
/media/media-library.htmlMedia library
/media/media-contacts.htmlMedia contacts
/media/media-library/scientifi...Scientific media resources
/media/media-library/disease-s...Disease state infographics
https://www.bms.com/media.htmlCorporate publications
https://www.bms.com/about-us.htmlAbout us
/about-us/our-company.htmlOur company
/about-us/leadership.htmlLeadership
/about-us/global-diversity-and...Global Inclusion & Diversity
/about-us/responsibility.htmlResponsibility
/about-us/sustainability.htmlSustainability at Bristol Myers Squibb
/about-us/contact-us.htmlText duplicate Contact us
/about-us/our-company/global-p...Global Patient Week
/about-us/our-company/survivor...Survivorship Today
/about-us/our-company/our-tech...Our technologies
/about-us/our-company/history-...History timeline
/about-us/our-company/worldwid...Worldwide locations
/about-us/responsibility/brist...The Bristol Myers Squibb Foundation
/about-us/global-diversity-and...People & Business Resource groups
/about-us/global-diversity-and...Our commitment to global inclusion and diversity
/about-us/responsibility/posit...Position on key issues
/life-and-science/science/rese...What is Bristol Myers Squibb’s research strategy and where are we taking it? Q&A with Robert Plenge, executive vice president and head of Research
IMG-ALT What is Bristol Myers Squibb’s research strategy and where are we taking it?
/life-and-science/news-and-per...Building a better future: Bristol Myers Squibb 2023 ESG report Read a message from our Board Chair and CEO
IMG-ALT Building a better future: Bristol Myers Squibb 2023 ESG report
https://news.bms.com/news/corp...New window External Subdomain Our latest cell therapy milestone > BMS has received accelerated approval from the FDA for our CAR T cell therapy to treat relapsed or refractory follicular ...
IMG-ALT Female scientist in lab with beaker
A-TITLE Our latest cell therapy milestone
/life-and-science/news-and-per...ASPIRE: Our commitment to address health inequities in low- and middle-income countries >
IMG-ALT ASPIRE: Our commitment to address health inequities in low- and middle-income countries
A-TITLE ASPIRE: Our commitment to address health inequities in low- and middle-income countries
/life-and-science/science/scie...Science Firsthand: Translating the promise of cell therapy >
IMG-ALT Science Firsthand: Translating the promise of cell therapy
A-TITLE Science Firsthand: Translating the promise of cell therapy
/life-and-science/science/car-...Bringing the science of cell therapy into autoimmune diseases >
IMG-ALT Bringing the science of cell therapy into autoimmune diseases
A-TITLE Bringing the science of cell therapy into autoimmune diseases
/life-and-science/science/rese...Researching lung cancer treatments to give more patients better outcomes >
IMG-ALT Researching lung cancer treatments to give more patients better outcomes
A-TITLE Researching lung cancer treatments to give more patients better outcomes
/media/media-library/scientifi...Scientific media resources > Our scientists are driven by curiosity to pursue the best outcomes possible for patients. Explore our strategic research approac...
A-TITLE Scientific Media Resources
/life-and-science/science/navi...Advancing cell therapy: Shaping our approach today to reach more patients tomorrow >
IMG-ALT Advancing cell therapy: Shaping our approach today to reach more patients tomorrow
A-TITLE Advancing cell therapy: Shaping our approach today to reach more patients tomorrow
https://esg.bms.com/New window External Subdomain View our ESG Report
https://esg.bms.com/New window External Subdomain IMG-ALT mosaic cover of esg report
/about-us/our-company/survivor...Learn more >
A-TITLE Learn more
https://careers.bms.com/jobsExternal Subdomain Text duplicate A-TITLE Careers
https://careers.bms.com/jobsExternal Subdomain Text duplicate Learn more >
A-TITLE Learn more
/investors.htmlText duplicate A-TITLE Investors
/investors.htmlText duplicate Learn more >
A-TITLE Learn more
/researchers-and-partners/clin...Text duplicate Learn more >
https://www.bmsstudyconnect.com/External Subdomain Find a clinical trial >
http://www.bmsmedinfo.com/New window External Subdomain Resources for U.S. healthcare providers >
http://www.globalbmsmedinfo.com/New window External Subdomain Global medical information >
/patient-and-caregivers/get-he...Find out how >
https://www.bms.com/Home
/patient-and-caregivers.htmlText duplicate Patients & caregivers
/healthcare-providers.htmlText duplicate Healthcare providers
/researchers-and-partners.htmlText duplicate Researchers
/investors.htmlText duplicate Investors
https://www.bms.com/media.htmlText duplicate News
https://www.bms.com/about-us.htmlText duplicate About us
/patient-and-caregivers/our-me...Text duplicate Our medicines
/legal-notice.htmlLegal notice
/privacy-policy.htmlPrivacy notice
/trademarks.htmlTrademarks
/forward-looking-statement.htmlNew window Forward-looking statement
/assets/bms/us/english-documen...UK-CA slavery and human trafficking statement (PDF)
http://www.facebook.com/Bristo...External Subdomain IMG-ALT Facebook
A-TITLE Facebook
https://www.instagram.com/bris...External Subdomain IMG-ALT Instagram
A-TITLE Instagram
http://twitter.com/BMSNEWSExternal IMG-ALT Twitter
A-TITLE Twitter
http://www.linkedin.com/compan...External Subdomain IMG-ALT LinkedIn
A-TITLE LinkedIn
http://www.youtube.com/bristol...External Subdomain IMG-ALT YouTube
A-TITLE YouTube
https://careers.bms.com/External Subdomain Text duplicate Careers
/life-and-science.htmlText duplicate Our stories
/about-us/contact-us.htmlText duplicate Contact us
/about-us/our-company/worldwid...Text duplicate Worldwide locations
https://www.bms.com/Bristol-Myers Squibb Company

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.bms.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time of 0.52 seconds is longer than the recommended limit of 0.4 seconds. A high response time unnecessarily slows down search engine crawling and results in bad user experience as well.
This page loads 9 JavaScript files. This may affect the load time negatively.
This page only loads 3 CSS files. That's ok.
The file size of the HTML document is fine (134 kB).

HTTP Response Header

NameValue
etag"216d7-619886c65d5d7-gzip"
last-modifiedTue, 28 May 2024 19:13:05 GMT
content-typetext/html;charset=utf-8
content-length20991
content-encodinggzip
cache-controlmax-age=600, public
age230
dateWed, 29 May 2024 00:16:48 GMT
set-cookie158 Characters
x-cdnImperva
x-iinfo1-2554484-0 0CNN RT(1716941808600 7) q(0 -1 -1 0) r(0 -1)
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 9,961 referring domains.
This page has 594,460 backlinks.
This page has backlinks from 6,497 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 14327 shares and comments on Facebook.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

User-agent: *
Disallow: /etc/tags/
Disallow: /apps/
Disallow: /crx/
Disallow: /libs/
Disallow: /bin/
Disallow:  /search-results/jcr:content/searchresults.searchresultsitems.html
Disallow: /content/bmsredesign/
Sitemap: https://www.bms.com/sitemap.xml

Similar sites

Search preview

www.bms.com
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Bristol Myers Squibb81%Check
Global73%Check
company73%Check
Biopharmaceutical73%Check
Global Biopharmaceutical Company73%Check
Bristol Myers Squibb 202369%Check
Myers Squibb 2023 ESG61%Check
Patients58%Check
BMS58%Check
Squibb 2023 ESG report52%Check
Show more keywords and terms

Test up to 1.000 webpages of bms.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions